513 related articles for article (PubMed ID: 18569926)
1. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
[TBL] [Abstract][Full Text] [Related]
2. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
[TBL] [Abstract][Full Text] [Related]
3. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
4. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
5. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.
Taneda S; Honda K; Ohno M; Uchida K; Nitta K; Oda H
Virchows Arch; 2015 Oct; 467(4):449-58. PubMed ID: 26266776
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
[TBL] [Abstract][Full Text] [Related]
7. Minimal change disease and idiopathic focal segmental glomerulosclerosis in adults. A quantitative study.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 1996; 47(4):209-14. PubMed ID: 9097714
[TBL] [Abstract][Full Text] [Related]
8. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
Srivastava T; Garola RE; Singh HK
Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
[TBL] [Abstract][Full Text] [Related]
9. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986
[TBL] [Abstract][Full Text] [Related]
10. Glomerular malondialdehyde levels in patients with focal and segmental glomerulosclerosis and minimal change disease.
Nezhad ST; Momeni B; Basiratnia M
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):886-91. PubMed ID: 20814126
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of focal segmental glomerulosclerosis: new insights.
D'Agati VD
Curr Opin Nephrol Hypertens; 2008 May; 17(3):271-81. PubMed ID: 18408478
[TBL] [Abstract][Full Text] [Related]
12. [Structure and function of the glomerular filtration barrier].
Musiał K; Zwolińska D
Pol Merkur Lekarski; 2005 Mar; 18(105):317-20. PubMed ID: 15997642
[TBL] [Abstract][Full Text] [Related]
13. Podocytes loose their adhesive phenotype in focal segmental glomerulosclerosis.
Kemeny E; Mihatsch MJ; Dürmüller U; Gudat F
Clin Nephrol; 1995 Feb; 43(2):71-83. PubMed ID: 7736682
[TBL] [Abstract][Full Text] [Related]
14. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
15. [Minimal change disease and focal segmental glomerulosclerosis in children--histomorphometric comparative study with application to computer image analysis].
Danilewicz M; Wagrowska-Danilewicz M
Przegl Lek; 1996; 53(7):529-33. PubMed ID: 8975287
[TBL] [Abstract][Full Text] [Related]
16. Increased glomerular and extracellular malondialdehyde levels in patients and rats with focal segmental glomerulosclerosis.
Kuo HT; Kuo MC; Chiu YW; Chang JM; Guh JY; Chen HC
Eur J Clin Invest; 2005 Apr; 35(4):245-50. PubMed ID: 15816993
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic significance of glomerular epithelial cell vacuolization and podocyte effacement in children with minimal lesion nephrotic syndrome and focal segmental glomerulosclerosis: an ultrastructural study.
Chiang ML; Hawkins EP; Berry PL; Barrish J; Hill LL
Clin Nephrol; 1988 Jul; 30(1):8-14. PubMed ID: 3061695
[TBL] [Abstract][Full Text] [Related]
18. Approach to Diagnosis and Management of Primary Glomerular Diseases Due to Podocytopathies in Adults: Core Curriculum 2020.
Ahn W; Bomback AS
Am J Kidney Dis; 2020 Jun; 75(6):955-964. PubMed ID: 32331832
[TBL] [Abstract][Full Text] [Related]
19. Ezrin--a useful factor in the prognosis of nephrotic syndrome in children: an immunohistochemical approach.
Ostalska-Nowicka D; Zachwieja J; Nowicki M; Kaczmarek E; Siwinska A; Witt M
J Clin Pathol; 2006 Sep; 59(9):916-20. PubMed ID: 16522749
[TBL] [Abstract][Full Text] [Related]
20. Modulation of podocyte phenotype in collapsing glomerulopathies.
Barisoni L; Kopp JB
Microsc Res Tech; 2002 May; 57(4):254-62. PubMed ID: 12012394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]